| Company Name: |
DC Chemicals
|
| Tel: |
021-58447131 13564518121 |
| Email: |
sales@dcchemicals.com |
| Products Intro: |
Product Name:PCI-33380
CAS:1022899-36-0
Purity:98% HPLC Package:100mg，250mg，1g
|
|
| | PCI-33380 Basic information |
| Product Name: | PCI-33380 | | Synonyms: | PCI-33380;(E)-N-(2-(4-(4-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-4-oxobut-2-en-1-yl)piperazin-1-yl)ethyl)-3-(5,5-difluoro-7,9-dimethyl-5H-5l4,6l4-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-3-yl)propanamide | | CAS: | 1022899-36-0 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![PCI-33380 Structure]() |
| | PCI-33380 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO:45.0(Max Conc. mg/mL);52.6(Max Conc. mM) | | form | Solid | | color | Pink to red |
| | PCI-33380 Usage And Synthesis |
| Description | PCI-33380 is a potent and irreversible Bruton's Tyrosine Kinase (BTK) inhibitor with a fluorescent probe. PCI-33380 was designed based on the ibrutinib scaffold and has been used in both cellular and in vivo studies that demonstrated the connection between the inhibitor binding event and phenotypic readouts of cellular responses due to the inhibition of Btk functions. Furthermore, the use of fluorescent probes in clinical trials has played an important role in determining the appropriate dosage of drugs for patients. |
| | PCI-33380 Preparation Products And Raw materials |
|